CN1646473A - 新的姜黄素类似物和其用途 - Google Patents
新的姜黄素类似物和其用途 Download PDFInfo
- Publication number
- CN1646473A CN1646473A CNA038086506A CN03808650A CN1646473A CN 1646473 A CN1646473 A CN 1646473A CN A038086506 A CNA038086506 A CN A038086506A CN 03808650 A CN03808650 A CN 03808650A CN 1646473 A CN1646473 A CN 1646473A
- Authority
- CN
- China
- Prior art keywords
- compound
- cancer
- nitro
- alkoxyl group
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/17—Saturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/172—Saturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
- C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pregnancy & Childbirth (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Abstract
Description
Claims (33)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/124,642 | 2002-04-17 | ||
US10/124,642 US6790979B2 (en) | 2002-04-17 | 2002-04-17 | Curcumin analogues and uses thereof |
PCT/US2003/009350 WO2003088927A2 (en) | 2002-04-17 | 2003-03-27 | Novel curcumin analogues and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1646473A true CN1646473A (zh) | 2005-07-27 |
CN1646473B CN1646473B (zh) | 2010-10-13 |
Family
ID=29248380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN038086506A Expired - Fee Related CN1646473B (zh) | 2002-04-17 | 2003-03-27 | 新的姜黄素类似物和其用途 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6790979B2 (zh) |
EP (1) | EP1494993B1 (zh) |
JP (2) | JP5108198B2 (zh) |
KR (2) | KR100984512B1 (zh) |
CN (1) | CN1646473B (zh) |
AT (1) | ATE466832T1 (zh) |
AU (1) | AU2003222087B8 (zh) |
CA (1) | CA2482002C (zh) |
DE (1) | DE60332445D1 (zh) |
DK (1) | DK1494993T3 (zh) |
ES (1) | ES2345930T3 (zh) |
HK (1) | HK1078846A1 (zh) |
MX (1) | MXPA04010180A (zh) |
NZ (1) | NZ535773A (zh) |
WO (1) | WO2003088927A2 (zh) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101255119A (zh) * | 2008-01-07 | 2008-09-03 | 沈阳药科大学 | 新型四氢姜黄素衍生物及盐类 |
CN102091060A (zh) * | 2009-12-10 | 2011-06-15 | 温州医学院 | 治疗或预防糖皮质激素介导的性腺功能减退性功能障碍和/或不育的药物及其应用 |
CN102126938A (zh) * | 2010-12-15 | 2011-07-20 | 厦门大学 | 一种姜黄素类似物及其制备方法和应用 |
CN101570515B (zh) * | 2009-06-12 | 2011-10-19 | 乐山师范学院 | 姜黄素取代嘧啶类衍生物及其制备方法与用途 |
CN101003470B (zh) * | 2007-01-22 | 2011-11-02 | 温州医学院生物与天然药物开发中心有限公司 | 姜黄素单羰基结构类似物及其用途 |
CN101805285B (zh) * | 2009-02-13 | 2012-02-22 | 南华大学 | 含烟酸姜黄素酯衍生物及其制造方法和用途 |
CN102381951A (zh) * | 2007-01-22 | 2012-03-21 | 温州医学院生物与天然药物开发中心有限公司 | 含环己酮的姜黄素单羰基结构类似物及其用途 |
CN102649750A (zh) * | 2012-04-11 | 2012-08-29 | 福建医科大学 | 姜黄素水杨酰单酯及其合成方法以及其在抗肿瘤、抗炎方面的应用 |
CN103159644A (zh) * | 2013-04-08 | 2013-06-19 | 唐山师范学院 | 类姜黄素缩芳香胺希夫碱衍生物及其制备方法和在制备抗菌药物的应用 |
CN103222970A (zh) * | 2013-04-10 | 2013-07-31 | 温州医学院 | 不对称单羰基姜黄素类似物在制备抗肿瘤药物中的应用 |
CN103254051A (zh) * | 2013-05-28 | 2013-08-21 | 常州大学 | 一种二烷基姜黄素的制备方法 |
CN102432447B (zh) * | 2007-01-22 | 2014-01-08 | 温州医学院生物与天然药物开发中心有限公司 | 含环戊酮的姜黄素单羰基结构类似物及其用途 |
CN103717588A (zh) * | 2011-04-11 | 2014-04-09 | 法玛艾特股份有限公司 | 新的吡唑衍生物 |
CN104557496A (zh) * | 2015-01-21 | 2015-04-29 | 温州医科大学 | 单羰基类化合物、组合物及在制备药物中的应用 |
CN104903297A (zh) * | 2012-10-10 | 2015-09-09 | 绿色科技株式会社 | 新型吡唑衍生物 |
CN106800547A (zh) * | 2017-01-03 | 2017-06-06 | 中国人民解放军第二军医大学 | 一种双取代芳基类化合物及其应用 |
WO2020024078A1 (zh) * | 2018-07-28 | 2020-02-06 | 苏州沪云新药研发股份有限公司 | 一种具有抗炎症性肠病作用的药物及其制备方法和应用 |
CN114746102A (zh) * | 2019-10-15 | 2022-07-12 | 萨米-萨宾莎集团有限公司 | 用于治疗性处理代谢综合征的姜黄素类组合物 |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6790979B2 (en) * | 2002-04-17 | 2004-09-14 | University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
US7355081B2 (en) * | 2002-04-17 | 2008-04-08 | The University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
WO2003105751A2 (en) * | 2002-06-17 | 2003-12-24 | Ho-Jeong Kwon | Novel curcumin derivatives |
DK1556058T3 (da) * | 2002-10-23 | 2008-03-03 | Pantarhei Bioscience Bv | Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi |
PT1624878E (pt) * | 2003-05-22 | 2007-01-31 | Pantarhei Bioscience Bv | Utilização de composições que compreendem um componente estrogénico para o tratamento e prevenção da dor musculoesquelética |
US20050049299A1 (en) * | 2003-08-26 | 2005-03-03 | Aggarwal Bharat B. | Selective inhibitors of stat-3 activation and uses thereof |
AU2004308260A1 (en) * | 2003-12-12 | 2005-07-14 | University Of Rochester | Non-androgen dependent roles for androgen receptor and non-androgen related inhibitors of androgen receptor |
US20060084704A1 (en) * | 2004-01-28 | 2006-04-20 | Charles Shih | Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof |
JP2007526913A (ja) * | 2004-01-28 | 2007-09-20 | アンドロサイエンス コーポレイション | ステロイド依存性の遺伝子活性化経路の異なる段階を標的とする阻害剤の組み合わせによる抗アンドロゲン活性の増強およびその使用 |
US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
AU2005282624A1 (en) * | 2004-09-02 | 2006-03-16 | Shih, Charles C-Y. | Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof |
WO2006033943A2 (en) * | 2004-09-17 | 2006-03-30 | Exelixis, Inc | Pyrazole kinase modulators and methods of use |
FR2880276A1 (fr) * | 2005-01-05 | 2006-07-07 | Lefebvre Dominique Caparros | Utilisation des anti-androgenes dans le traitement des comportements agressifs ou impulsifs induits par des maladies du systeme nerveux central |
JP2009537142A (ja) * | 2006-05-19 | 2009-10-29 | ユニバーシティー オブ ロチェスター | 前立腺上皮アンドロゲン受容体は、前立腺の成長および腫瘍の侵襲を抑制する |
US7507864B2 (en) * | 2006-08-01 | 2009-03-24 | Salisbury University | Method for the synthesis of curcumin analogues |
EP2076129B1 (en) * | 2006-10-12 | 2016-05-04 | Research Foundation Of The City University Of New York | Novel curcumin dimer |
WO2008085984A1 (en) * | 2007-01-08 | 2008-07-17 | Androscience Corporation | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof |
US9000222B2 (en) | 2007-01-08 | 2015-04-07 | Androscience Corporation | Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof |
US8710272B2 (en) | 2007-01-08 | 2014-04-29 | Androscience Corporation | Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof |
US8383865B2 (en) * | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
EP2136797A4 (en) * | 2007-04-17 | 2013-08-21 | Codman & Shurtleff | INTRANASAL ADMINISTRATION OF CURCUMINE IN A HELIUM GAS BOLUS FOR THE TREATMENT OF MORBUS ALZHEIMER |
KR20100051808A (ko) | 2007-07-31 | 2010-05-18 | 앤드로사이언스 코포레이션 | 안드로겐 수용체 분해 강화제를 포함한 조성물 및 탈모와 피부질환의 예방 또는 치료 방법 |
US20090282496A1 (en) * | 2008-04-04 | 2009-11-12 | University Of Rochester Medical Center | Androgen Receptor Related Methods for Treating Bladder Cancer |
US8552220B2 (en) | 2008-05-30 | 2013-10-08 | Tokyo Institute Of Technology | Therapeutic agent for Alzheimer's disease |
CN101434525B (zh) * | 2008-06-05 | 2012-07-04 | 福建医科大学 | 4-(4-羟基-3-甲氧基苯甲基)姜黄素及其用于制备抗肿瘤药物的应用 |
US7985776B2 (en) * | 2008-06-27 | 2011-07-26 | Codman & Shurtleff, Inc. | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease |
US9221877B2 (en) * | 2008-09-19 | 2015-12-29 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Curcumin conjugates for treating and preventing cancers |
US20100286585A1 (en) * | 2009-01-26 | 2010-11-11 | Codman & Shurtleff, Inc. | Shunt Delivery of Curcumin |
US7723515B1 (en) * | 2009-01-26 | 2010-05-25 | Codman & Shurtleff, Inc. | Methylene blue—curcumin analog for the treatment of alzheimer's disease |
US9187406B2 (en) | 2009-05-15 | 2015-11-17 | The Research Foundation Of State University Of New York | Curcumin analogues as zinc chelators and their uses |
WO2011116066A1 (en) | 2010-03-17 | 2011-09-22 | Concert Pharmaceuticals, Inc. | Derivatives of dimethylcurcumin |
US9296716B2 (en) * | 2011-11-23 | 2016-03-29 | The Provost, Fellows, Foundation Scholars, & The Other Members Of Board, Of The College Of The Holy And Undiv. Trinity Of Queen Elizabeth Near Dublin | Androgen receptor ligands |
CN106220507A (zh) * | 2012-06-18 | 2016-12-14 | 有联生技股份有限公司 | 具有(1e,6e)‑1,7‑双‑(3,4‑二甲氧基苯基)‑4,4‑二取代的庚‑1,6‑二烯‑3,5‑二酮结构骨架的化合物及其用途 |
EP2866795A4 (en) | 2012-06-29 | 2016-01-27 | Univ New York State Res Found | POLYENOLZIN BINDER FOR THE ACTIVE PROMOTION OF THE INACTIVATION OF CANCER STRAIN CELLS AND FOR THE POTENTIATING OF CYTOTOXIC ANTITUMOROUS SUBSTANCES |
US20160008297A1 (en) * | 2012-08-23 | 2016-01-14 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
JP6369751B2 (ja) * | 2014-09-05 | 2018-08-08 | 二村 芳弘 | ケラチン産生作用を呈するクルクミン誘導体及びその製造方法 |
US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
US9402834B2 (en) | 2014-10-21 | 2016-08-02 | Ions Pharmaceutical S.À R.L. | Human therapeutic agents |
US11135318B2 (en) * | 2016-06-29 | 2021-10-05 | The General Hospital Corporation | Half-curcuminoids as amyloid-beta PET imaging agents |
US10300000B2 (en) | 2016-09-12 | 2019-05-28 | The Research Foundation For The State University Of New York | Inhibition of melanogenesis by chemically modified curcumins |
US20190358138A1 (en) * | 2017-02-15 | 2019-11-28 | Conopco, Inc., D/B/A Unilever | A personal care composition |
AU2018261331C1 (en) | 2017-05-01 | 2022-08-04 | Spg Therapeutics, Inc. | Tripartite androgen receptor eliminators, methods and uses thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07165724A (ja) * | 1993-12-13 | 1995-06-27 | Nkk Corp | ピラゾール誘導体及び血液凝固阻害剤 |
IL112205A0 (en) * | 1994-01-06 | 1995-03-15 | Res Dev Foundation | Curcumin, analogues of curcumin and novel uses thereof |
US5565491A (en) * | 1994-01-31 | 1996-10-15 | Bristol-Myers Squibb Company | Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation |
US5679864A (en) * | 1995-11-03 | 1997-10-21 | Gene Print Inc. | Process for the synthesis of curcumin-related compounds |
EP1027045A4 (en) * | 1997-10-31 | 2004-12-08 | Arch Dev Corp | METHODS AND COMPOSITIONS FOR REGULATING 5-ALPHA-REDUCTASE ACTIVITY |
JP2000258904A (ja) * | 1999-03-04 | 2000-09-22 | Fujifilm Olin Co Ltd | ネガ型化学増幅系感光性組成物 |
US6673843B2 (en) * | 1999-06-30 | 2004-01-06 | Emory University | Curcumin and curcuminoid inhibition of angiogenesis |
WO2001030335A2 (en) | 1999-10-22 | 2001-05-03 | The Board Of Trustees Of The University Of Illinois | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease |
JP2003515590A (ja) | 1999-12-03 | 2003-05-07 | エモリー ユニバーシティ | 癌を処置するためのクルクミンアナログ |
US6790979B2 (en) * | 2002-04-17 | 2004-09-14 | University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
US20060069151A1 (en) * | 2002-12-06 | 2006-03-30 | Luca Barella | Novel use of lycopene |
WO2004080396A2 (en) * | 2003-03-07 | 2004-09-23 | The University Of Texas Md Anderson Cancer Center | Liposomal curcumin for treatment of cancer |
-
2002
- 2002-04-17 US US10/124,642 patent/US6790979B2/en not_active Expired - Lifetime
-
2003
- 2003-03-27 KR KR1020047016357A patent/KR100984512B1/ko active IP Right Grant
- 2003-03-27 DK DK03718072.6T patent/DK1494993T3/da active
- 2003-03-27 AT AT03718072T patent/ATE466832T1/de not_active IP Right Cessation
- 2003-03-27 WO PCT/US2003/009350 patent/WO2003088927A2/en active Search and Examination
- 2003-03-27 AU AU2003222087A patent/AU2003222087B8/en not_active Revoked
- 2003-03-27 KR KR1020097018211A patent/KR101025226B1/ko not_active IP Right Cessation
- 2003-03-27 CN CN038086506A patent/CN1646473B/zh not_active Expired - Fee Related
- 2003-03-27 ES ES03718072T patent/ES2345930T3/es not_active Expired - Lifetime
- 2003-03-27 CA CA2482002A patent/CA2482002C/en not_active Expired - Lifetime
- 2003-03-27 NZ NZ535773A patent/NZ535773A/en not_active IP Right Cessation
- 2003-03-27 MX MXPA04010180A patent/MXPA04010180A/es active IP Right Grant
- 2003-03-27 EP EP03718072A patent/EP1494993B1/en not_active Expired - Lifetime
- 2003-03-27 JP JP2003585680A patent/JP5108198B2/ja not_active Expired - Fee Related
- 2003-03-27 DE DE60332445T patent/DE60332445D1/de not_active Expired - Lifetime
-
2005
- 2005-11-23 HK HK05110609.7A patent/HK1078846A1/xx not_active IP Right Cessation
-
2010
- 2010-01-25 JP JP2010012930A patent/JP2010150266A/ja active Pending
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101003470B (zh) * | 2007-01-22 | 2011-11-02 | 温州医学院生物与天然药物开发中心有限公司 | 姜黄素单羰基结构类似物及其用途 |
CN102381951B (zh) * | 2007-01-22 | 2013-09-04 | 温州医学院生物与天然药物开发中心有限公司 | 含环己酮的姜黄素单羰基结构类似物及其用途 |
CN102432447B (zh) * | 2007-01-22 | 2014-01-08 | 温州医学院生物与天然药物开发中心有限公司 | 含环戊酮的姜黄素单羰基结构类似物及其用途 |
CN102381951A (zh) * | 2007-01-22 | 2012-03-21 | 温州医学院生物与天然药物开发中心有限公司 | 含环己酮的姜黄素单羰基结构类似物及其用途 |
CN101255119B (zh) * | 2008-01-07 | 2014-05-21 | 沈阳药科大学 | 四氢姜黄素衍生物及盐类 |
CN101255119A (zh) * | 2008-01-07 | 2008-09-03 | 沈阳药科大学 | 新型四氢姜黄素衍生物及盐类 |
CN101805285B (zh) * | 2009-02-13 | 2012-02-22 | 南华大学 | 含烟酸姜黄素酯衍生物及其制造方法和用途 |
CN101570515B (zh) * | 2009-06-12 | 2011-10-19 | 乐山师范学院 | 姜黄素取代嘧啶类衍生物及其制备方法与用途 |
CN102091060A (zh) * | 2009-12-10 | 2011-06-15 | 温州医学院 | 治疗或预防糖皮质激素介导的性腺功能减退性功能障碍和/或不育的药物及其应用 |
CN102126938B (zh) * | 2010-12-15 | 2013-03-27 | 厦门大学 | 一种姜黄素类似物及其制备方法和应用 |
CN102126938A (zh) * | 2010-12-15 | 2011-07-20 | 厦门大学 | 一种姜黄素类似物及其制备方法和应用 |
CN103717588B (zh) * | 2011-04-11 | 2016-08-03 | 绿色科技株式会社 | 吡唑衍生物 |
CN103717588A (zh) * | 2011-04-11 | 2014-04-09 | 法玛艾特股份有限公司 | 新的吡唑衍生物 |
CN102649750B (zh) * | 2012-04-11 | 2014-01-22 | 福建医科大学 | 姜黄素水杨酰单酯及其合成方法以及其在抗肿瘤、抗炎方面的应用 |
CN102649750A (zh) * | 2012-04-11 | 2012-08-29 | 福建医科大学 | 姜黄素水杨酰单酯及其合成方法以及其在抗肿瘤、抗炎方面的应用 |
CN104903297A (zh) * | 2012-10-10 | 2015-09-09 | 绿色科技株式会社 | 新型吡唑衍生物 |
CN103159644B (zh) * | 2013-04-08 | 2015-04-15 | 唐山师范学院 | 类姜黄素缩芳香胺希夫碱衍生物及其在制备抗菌药物的应用 |
CN103159644A (zh) * | 2013-04-08 | 2013-06-19 | 唐山师范学院 | 类姜黄素缩芳香胺希夫碱衍生物及其制备方法和在制备抗菌药物的应用 |
CN103222970A (zh) * | 2013-04-10 | 2013-07-31 | 温州医学院 | 不对称单羰基姜黄素类似物在制备抗肿瘤药物中的应用 |
CN103222970B (zh) * | 2013-04-10 | 2019-03-26 | 温州医科大学 | 不对称单羰基姜黄素类似物在制备抗肿瘤药物中的应用 |
CN103254051A (zh) * | 2013-05-28 | 2013-08-21 | 常州大学 | 一种二烷基姜黄素的制备方法 |
CN104557496A (zh) * | 2015-01-21 | 2015-04-29 | 温州医科大学 | 单羰基类化合物、组合物及在制备药物中的应用 |
CN106800547A (zh) * | 2017-01-03 | 2017-06-06 | 中国人民解放军第二军医大学 | 一种双取代芳基类化合物及其应用 |
CN106800547B (zh) * | 2017-01-03 | 2019-07-23 | 中国人民解放军第二军医大学 | 一种双取代芳基类化合物及其应用 |
WO2020024078A1 (zh) * | 2018-07-28 | 2020-02-06 | 苏州沪云新药研发股份有限公司 | 一种具有抗炎症性肠病作用的药物及其制备方法和应用 |
CN111315370A (zh) * | 2018-07-28 | 2020-06-19 | 苏州沪云新药研发股份有限公司 | 一种具有抗炎症性肠病作用的药物及其制备方法和应用 |
US11602514B2 (en) | 2018-07-28 | 2023-03-14 | Suzhou Pharmavan Co., Ltd | Medicament having anti-inflammatory bowel disease function, and preparation method therefor and application thereof |
CN111315370B (zh) * | 2018-07-28 | 2023-09-29 | 苏州沪云新药研发股份有限公司 | 一种具有抗炎症性肠病作用的药物及其制备方法和应用 |
CN114746102A (zh) * | 2019-10-15 | 2022-07-12 | 萨米-萨宾莎集团有限公司 | 用于治疗性处理代谢综合征的姜黄素类组合物 |
Also Published As
Publication number | Publication date |
---|---|
DK1494993T3 (da) | 2010-08-23 |
JP2005534626A (ja) | 2005-11-17 |
AU2003222087B8 (en) | 2008-09-04 |
KR20050009989A (ko) | 2005-01-26 |
EP1494993A4 (en) | 2005-09-14 |
WO2003088927A2 (en) | 2003-10-30 |
US6790979B2 (en) | 2004-09-14 |
EP1494993B1 (en) | 2010-05-05 |
KR100984512B1 (ko) | 2010-09-30 |
WO2003088927A3 (en) | 2004-04-01 |
KR20090132590A (ko) | 2009-12-30 |
CA2482002C (en) | 2012-07-17 |
HK1078846A1 (en) | 2006-03-24 |
JP2010150266A (ja) | 2010-07-08 |
CN1646473B (zh) | 2010-10-13 |
ATE466832T1 (de) | 2010-05-15 |
ES2345930T3 (es) | 2010-10-06 |
EP1494993A2 (en) | 2005-01-12 |
US20030203933A1 (en) | 2003-10-30 |
JP5108198B2 (ja) | 2012-12-26 |
DE60332445D1 (de) | 2010-06-17 |
AU2003222087B2 (en) | 2008-08-21 |
MXPA04010180A (es) | 2005-02-03 |
CA2482002A1 (en) | 2003-10-30 |
NZ535773A (en) | 2007-01-26 |
KR101025226B1 (ko) | 2011-04-01 |
AU2003222087A1 (en) | 2003-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1646473A (zh) | 新的姜黄素类似物和其用途 | |
US7355081B2 (en) | Curcumin analogues and uses thereof | |
KR101717098B1 (ko) | 디글리시드 에테르 유도체 치료법 및 이의 사용 방법 | |
EP2744773B1 (en) | Fluorinated bisphenol ether compounds and methods for their use | |
AU2014262333B2 (en) | Ester derivatives of androgen receptor modulators and methods for their use | |
WO2016058080A1 (en) | Fluoro-chloro bisphenol ether compounds and methods for their use | |
CN1305465A (zh) | 芳基链烷酰基哒嗪化合物 | |
CN1123280A (zh) | 新型吡咯并咔唑衍生物 | |
AU2009215207B2 (en) | Novel curcumin analogues and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1078846 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090522 Address after: North Carolina Applicant after: University OF NORTH CAROLINA AT CHAPEL HILL Co-applicant after: University ROCHESTER MEDICAL CT Co-applicant after: ANDROSCIENCE COR Address before: North Carolina Applicant before: University OF NORTH CAROLINA AT CHAPEL HILL |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1078846 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101013 |
|
CF01 | Termination of patent right due to non-payment of annual fee |